Guo-qiang Li
Shanghai, 200062, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Synthesis of heterocyclic ring-fused analogs of HMG499 as novel degraders of HMG-CoA reductase that lower cholesterol.
Journal: European journal of medicinal chemistry
Published: January 07, 2022
iTRAQ- and LC-MS/MS-based quantitative proteomics reveals Pqlc2 as a potential regulator of hepatic glucose metabolism and insulin signalling pathway during fasting.
Journal: Clinical and experimental pharmacology & physiology
Published: June 09, 2020
Nicotinamide phosphoribosyltransferase aggravates inflammation and promotes atherosclerosis in ApoE knockout mice.
Journal: Acta pharmacologica Sinica
Published: September 30, 2018
NAD replenishment with nicotinamide mononucleotide protects blood-brain barrier integrity and attenuates delayed tissue plasminogen activator-induced haemorrhagic transformation after cerebral ischaemia.
Journal: British journal of pharmacology
Published: January 04, 2017
Nicotinamide mononucleotide attenuates brain injury after intracerebral hemorrhage by activating Nrf2/HO-1 signaling pathway.
Journal: Scientific reports
Published: November 23, 2016
Hepatic NAD(+) deficiency as a therapeutic target for non-alcoholic fatty liver disease in ageing.
Journal: British journal of pharmacology
Published: November 30, 2015
Regenerative Neurogenesis After Ischemic Stroke Promoted by Nicotinamide Phosphoribosyltransferase-Nicotinamide Adenine Dinucleotide Cascade.
Journal: Stroke
Published: April 20, 2015
Showing 1-8 of 8
Last Updated: 09/26/2026